Investor relations

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.

Observe Medical is listed on Euronext Oslo under OBSRV.

Read our latest regulatory news

Observe Medical secures new funding

Oslo, 11 September 2023 – Observe Medical ASA (the "Company" or "Observe Medical") has secured new loans with the largest shareholders totaling NOK 7.25 million (the "Loans"). The Loans will be used to finance the first instalment under the asset transfer agreement with Unomedical and running business. The Company will immediately receive payment of NOK…

Read more

Observe Medical signs milestone agreement with Unomedical

Oslo, 11 September 2023 – Observe Medical ASA ("Observe Medical" or the "Company") has, through its wholly owned subsidiary Observe Medical AS ("OMAS"), signed an asset transfer agreement with Unomedical A/S and Unomedical s.r.o. as sellers (which are ultimately owned by Convatec Group Plc) (the "ATA"), following the entry of an exclusivity agreement in October…

Read more

SECOND QUARTER AND FIRST HALF YEAR OF 2023 REPORT

Oslo, August 25, 2023 – The Board of Directors of Observe Medical ASA has approved the unaudited group financial results for the second quarter and first half year of 2023. Please find attached the Interim Report. FOR FURTHER INFORMATION, PLEASE CONTACT: Rune Nystad, CEO Observe Medical Mobile: +47 916 24 683 E-mail: rune.nystad@observemedical.com Per Arne…

Read more

Reports and presentations

Prospectus

Financial calendar

  • 17 February 2023

    Quarterly Presentation - Q4 2022

  • 28 April 2023

    Annual Report 2022

  • 26 May 2023

    Annual General Meeting

  • 25 August 2023

    First Half Year 2023 Report

The Share

Share performance

Shareholders

As at 22 June 2023.

NameNumber of shares% of top 20% of total Country
1INGERØ REITEN INVESTMENT COMPANY AS9,653,680

28.86%

18.05%Norway
2NAVAMEDIC ASA4,222,727

12.62%

7.89%Norway
3RO, LARS

3,426,789

10.24%

6.41%

Norway
4JPB AS2,830,209

8.46%

5.29%Norway
5ELI AS1,744,260

5.21%

3.26%Norway
6MP PENSJON PK1,676,188

5.01%

3.13%Norway
7UBS Switzerland AG1,482,913

4.43%

2.77%Switzerland
8SKÅLVOLD EIENDOM AS

951,868

2.85%

1.78%

Norway
9NORDNET LIVSFORSIKRING AS

842,942

2.52%

1.58%

Norway
10BJØRNTVEDT, VEGARD

904,979

2.71%

1.69%

Norway
11LAPAS AS805,185

2.41%

1.51%Norway
12Nordnet Bank AB

683,579

2.04%

1.28%

Sweden
13SILVERCOIN INDUSTRIES AS

588,130

1.76%

1.10%

Norway
14SOLEGLAD INVEST AS586,668

1.75%

1.10%Norway
15

BJØRNTVEDT, HARALD

536,558

1.60%

1.00%

Norway
16

ELMON AS

510,550

1.53%

0.95%

Norway
17

HAMARA INVEST AS

502,703

1.50%

0.94%

Norway
18

TAJ HOLDING AS

500,847

1.50%

0.94%

Norway
19

GINNY INVEST AS

500,000

1.49%

0.93%

Norway
20

TRANBERGKOLLEN INVEST AS

500,000

1.49%

0.93%

Norway
Total number owned by top 20

33,450,775

100.00%

62.53%

Total number of shares 53,491,656
Total number of shareholders

1,974

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

53 491 656

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

General meeting

2023

26 May 2023: Observe Medical ASA - Minutes from Annual General Meeting

26 May 2023: Represented List

 

5 May 2023:Notice of Annual General Meeting on 26 May 2023

5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023

5 May 2023: VPS - Investor services

5 May 2023: Nomination Committee recommendation

5 May 2023: Observe Medical - Report of salary and other remuneration to leading personnel

 

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee's recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

Corporate Governance Principles
Instructions for the Nomination Committee

IR contact

Rune Nystad, Chief Executive Officer                                                                         +47 91 62 46 83 / rune.nystad@observemedical.com

Per Arne Nygård, Chief Financial Officer                                                              +47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list